Phase 1 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand what the trial involves and sign a consent form.
- People aged 18 to 45 years old at the time of signing the consent form.
- Men who weigh at least 50 kg and women who weigh at least 45 kg, with a body mass index (BMI) between 18 and 28.
- People whose health test results are normal, or show only minor findings that the trial doctor considers not medically significant.
- Women who could become pregnant, and men (along with their female partners), must agree to use highly effective birth control methods during the trial.
Who may not be able to join:
- People who have a history of severe allergic reactions, or who have had an allergic reaction to the study treatment or its ingredients.
- People who have had any significant health conditions before the screening visit, or who test positive for hepatitis B, hepatitis C, or HIV.
- People with a history of significant alcohol misuse.
- People with a history of significant drug misuse.
- People who test positive for nicotine in a urine test at screening, or who are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 189113015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events (AEs) and serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.